Progress in metabolomics research of diabetes
Xin LI; Hai-yan MA; Lu-pan LI; Shan-shan SUN; Li-jun ZHU; Yu-feng LIU.
Acta Pharmaceutica Sinica
; (12): 828-837, 2019.
ArtÃculo en Zh | WPRIM | ID: wpr-780192
Documentos relacionados
Biomedical research in france and brazil: an analysis of significant differences and ethical issues
Measuring the human immune response to surgery: multiomics for the prediction of postoperative outcomes.
Prognostic Biomarkers in Kidney Transplantation: A Systematic Review and Critical Appraisal.
Clinical monitoring in osteoarthritis: Biomarkers.
Biomarker-guided drug development provides value for patients, payers and drug developers: lessons learned from 25 years in the biomarker industry.
Proteins and metabolites fingerprints of gestational diabetes mellitus forming protein-metabolite interactomes are its potential biomarkers.
Edge-based relative entropy as a sensitive indicator of critical transitions in biological systems.
Novel Biomarkers in Membranous Nephropathy.
Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension.
Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma.